These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7067393)

  • 1. Safe and effective use of sustained-release and intravenous theophylline.
    Boggs PB
    Compr Ther; 1982 Mar; 8(3):17-21. PubMed ID: 7067393
    [No Abstract]   [Full Text] [Related]  

  • 2. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
    Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for determination of the optimum dosage of E-0686. A new sustained-release preparation of theophylline].
    Miyamoto T; Takishima T; Satake T; Kabe J; Baba M; Mikawa H; Teramichi Y; Iikura Y
    Arerugi; 1986 Apr; 35(4):250-61. PubMed ID: 3741151
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL; Maddux MS; Organek HW; Bauman JL
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma].
    Huerta JG; Moguel A
    Rev Alerg Mex (1987); 1988; 35(2):41-6. PubMed ID: 3389490
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early replacement of intravenous aminophylline administration with oral theophylline in treating acute exacerbation of asthma].
    Ono Y; Kondo T; Tanigaki T; Syouyama Y; Moue Y; Kamiya U; Tazaki G; Ohta Y
    Nihon Kokyuki Gakkai Zasshi; 2001 Feb; 39(2):75-81. PubMed ID: 11321830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous treatment of asthma in children with theophylline retard].
    de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
    Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are theophylline determinations useful to the clinician during treatment with a sustained-release form of theophylline?].
    Autret E; Lebranchu Y; Blanchard P; Nsabiyumua F; Breteau M; Grenier B; Jonville AP
    Therapie; 1990; 45(1):19-22. PubMed ID: 2343431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary results of a new delayed-action theophylline preparation (1 dose in 24 hours) in the treatment of childhood asthma].
    Ciofetta G; Indinnimeo L; De Castro G; Lo Tesoriere A; Barretta MA; Lalia F; Zicari AM; Ronchetti R
    Minerva Pediatr; 1986 Oct; 38(19):843-8. PubMed ID: 3796546
    [No Abstract]   [Full Text] [Related]  

  • 19. Simple conversion from intravenous aminophylline to twice daily oral theophylline.
    Pleasants RA; Williams DM
    Chest; 1989 Dec; 96(6):1440. PubMed ID: 2582862
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.